Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People
Phase 4
Recruiting
- Conditions
- HIV InfectionsHepatitis AImmunodeficiency
- Interventions
- Biological: 2 doses of HAVBiological: At least one dose of HAV
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- LiuZhou People's Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06576024
- Locations
- 🇨🇳
Liuzhou People's Hospital, Liuzhou, Guangxi, China
Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports
- First Posted Date
- 2020-03-16
- Last Posted Date
- 2020-03-16
- Lead Sponsor
- LiuZhou People's Hospital
- Target Recruit Count
- 204
- Registration Number
- NCT04309240
© Copyright 2025. All Rights Reserved by MedPath